NovoCure Ltd. (NVCR)
17.65
-0.17
(-0.95%)
USD |
NASDAQ |
Aug 31, 16:00
17.66
0.00 (0.00%)
After-Hours: 20:00
NovoCure Net Income (Quarterly) : -15.66M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -15.66M |
| March 31, 2026 | -71.14M |
| December 31, 2025 | -24.50M |
| September 30, 2025 | -37.27M |
| June 30, 2025 | -40.14M |
| March 31, 2025 | -34.32M |
| December 31, 2024 | -65.92M |
| September 30, 2024 | -30.57M |
| June 30, 2024 | -33.38M |
| March 31, 2024 | -38.76M |
| December 31, 2023 | -47.08M |
| September 30, 2023 | -49.48M |
| June 30, 2023 | -57.42M |
| March 31, 2023 | -53.06M |
| December 31, 2022 | -37.30M |
| September 30, 2022 | -26.58M |
| June 30, 2022 | -24.01M |
| March 31, 2022 | -4.647M |
| December 31, 2021 | -26.46M |
| September 30, 2021 | -13.12M |
| June 30, 2021 | -14.64M |
| March 31, 2021 | -4.128M |
| December 31, 2020 | 4.917M |
| September 30, 2020 | 9.284M |
| Date | Value |
|---|---|
| June 30, 2020 | 1.655M |
| March 31, 2020 | 3.952M |
| December 31, 2019 | 4.26M |
| September 30, 2019 | 1.93M |
| June 30, 2019 | -1.27M |
| March 31, 2019 | -12.15M |
| December 31, 2018 | -15.63M |
| September 30, 2018 | -11.69M |
| June 30, 2018 | -15.51M |
| March 31, 2018 | -20.72M |
| December 31, 2017 | -10.94M |
| September 30, 2017 | -11.50M |
| June 30, 2017 | -21.17M |
| March 31, 2017 | -18.04M |
| December 31, 2016 | -22.17M |
| September 30, 2016 | -33.63M |
| June 30, 2016 | -40.61M |
| March 31, 2016 | -35.44M |
| December 31, 2015 | -32.93M |
| September 30, 2015 | -26.02M |
| June 30, 2015 | -29.36M |
| March 31, 2015 | -23.27M |
| June 30, 2014 | -21.33M |
| March 31, 2014 | -18.12M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| LivaNova Plc | 108.57M |
| EKF Diagnostics Holdings Plc | -- |
| Niox Group Plc | -- |
| Polarean Imaging Plc | -- |
| Accuray, Inc. | -1.941M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 183.58M |
| Total Expenses (Quarterly) | 199.24M |
| EPS Diluted (Quarterly) | -0.135 |
| Enterprise Value | 1.838B |
| Gross Profit Margin (Quarterly) | 77.61% |
| Profit Margin (Quarterly) | -8.53% |
| Earnings Yield | -7.42% |
| Normalized Earnings Yield | -7.419 |